Logo-npj

J Nephropharmacol. 2021;10(2): e16. doi: 10.34172/npj.2021.16

Review

Potential of renin-angiotensin system inhibition to improve metabolic bone disorders

Mahnaz Momenzadeh 1 * ORCID, Maryam Khosravian 2 ORCID, Bhaskar VKS Lakkakula 3 ORCID

Cited by CrossRef: 4

1- Valilshchykov M, Babalyan V, Ionov I, Babaieva O. Peculiarities of Reparative Osteogenesis in Fractures of the Proximal Femur in Patients with Concomitant Arterial Hypertension. Biomed Pharmacol J. 2021;14(4):1815 [Crossref]
2- Fan Z, Kitaura H, Ren J, Ohori F, Noguchi T, Marahleh A, Ma J, Kanou K, Miura M, Narita K, Lin A, Mizoguchi I. Azilsartan inhibits inflammation-triggered bone resorption and osteoclastogenesis in vivo via suppression of TNF-α expression in macrophages. Front Endocrinol. 2023;14 [Crossref]
3- Mkhize B, Mosili P, Ngubane P, Sibiya N, Khathi A. The Relationship between Renin–Angiotensin–Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes. IJMS. 2023;24(15):11963 [Crossref]
4- PAVLOV S, BABALYAN V, VALILSHCHIKOV M, BABENKO N, KUMETCHKO M, LITVINOVA O, SEMKO N. The role of cytokines in the mechanisms of regulation of reparative processes in modeling fractures of the proximal femur secondary to the correction of concomitant arterial hypertension. Minerva Orthop. 2022;73(3) [Crossref]